Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.55p on 09-05-2025 at 18:20:12
Change 0.00p 0%
Buy 0.60p
Sell 0.50p
Buy / Sell VAL Shares
Last Trade: Sell 100,000.00 at 0.54p
Day's Volume: 498,834
Last Close: 0.55p
Open: 0.55p
ISIN: GB00BLH13C52
Day's Range 0.55p - 0.55p
52wk Range: 0.39p - 4.35p
Market Capitalisation: £2m
VWAP: 0.534925p
Shares in Issue: 374m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100,000 0.54p Ordinary
16:28:28 - 09-May-25
Sell* 170,000 0.5375p Ordinary
16:18:28 - 09-May-25
Sell* 1,833 0.501p Ordinary
14:23:47 - 09-May-25
Sell* 60,000 0.54p Ordinary
08:31:11 - 09-May-25
Sell* 95,000 0.511p Ordinary
08:08:22 - 09-May-25
Sell* 72,001 0.55p Ordinary
08:06:06 - 09-May-25
Buy* 26,000 0.56p Ordinary
16:23:55 - 08-May-25
Buy* 233 0.5985p Ordinary
14:18:06 - 08-May-25
Sell* 215,919 0.5075p Ordinary
13:55:38 - 08-May-25
Sell* 200,000 0.51p Ordinary
13:01:07 - 08-May-25
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
9th May 2025 (Fri) 0.55 0.55 0.55 0.55 498,834
8th May 2025 (Thu) 0.55 0.55 0.55 0.55 583,065
7th May 2025 (Wed) 0.55 0.55 0.55 0.55 615,155
6th May 2025 (Tue) 0.50 0.55 0.50 0.55 2,169,856
5th May 2025 (Mon) 0.4675 0.4675 0.4675 0.4675 0
2nd May 2025 (Fri) 0.50 0.50 0.50 0.50 1,284,727
1st May 2025 (Thu) 0.50 0.50 0.50 0.50 754,129
30th Apr 2025 (Wed) 0.50 0.50 0.50 0.50 456,247
29th Apr 2025 (Tue) 0.475 0.475 0.475 0.475 385,000
28th Apr 2025 (Mon) 0.50 0.50 0.475 0.475 1,382,546
25th Apr 2025 (Fri) 0.50 0.50 0.50 0.50 33,323
24th Apr 2025 (Thu) 0.50 0.50 0.50 0.50 1,279,778
23rd Apr 2025 (Wed) 0.50 0.50 0.50 0.50 1,915,655
22nd Apr 2025 (Tue) 0.50 0.50 0.50 0.50 927,457
21st Apr 2025 (Mon) 0.50 0.50 0.50 0.50 0
18th Apr 2025 (Fri) 0.50 0.50 0.50 0.50 0
17th Apr 2025 (Thu) 0.50 0.50 0.50 0.50 640,582
16th Apr 2025 (Wed) 0.50 0.50 0.50 0.50 96,951
15th Apr 2025 (Tue) 0.50 0.50 0.50 0.50 291,099
14th Apr 2025 (Mon) 0.525 0.525 0.50 0.50 1,169,276
11th Apr 2025 (Fri) 0.525 0.525 0.525 0.525 594,009
10th Apr 2025 (Thu) 0.525 0.525 0.525 0.525 290,786
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
30th Apr 2025 7:00 am RNS Commercial Update
3rd Apr 2025 7:00 am RNS Termination of Letter of Intent with TheoremRx
27th Mar 2025 7:00 am RNS Directorate Changes and new Advisory Board
21st Mar 2025 11:07 am RNS Director Disclosure Update
24th Feb 2025 7:00 am RNS Conclusion of Evaluation Project
3rd Feb 2025 7:00 am RNS Inaphaea Evaluation and Commercial Use Agreement
30th Jan 2025 7:00 am RNS Extension of Evaluation Agreement
29th Jan 2025 7:00 am RNS New Evaluation and Option Agreement
15th Jan 2025 12:47 pm RNS Holding(s) in Company
15th Jan 2025 11:29 am RNS Holding(s) in Company
See more ValiRx regulatory news

ValiRx (VAL) Share News

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract

4th Apr 2025 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

LONDON MARKET OPEN: Europe, Asia down as investors digest US tariffs

3rd Apr 2025 09:01

(Alliance News) - London stocks slumped alongside Asian and European peers at Thursday's market open, as US tariff announcements and the prospect of trade war throws the global market into turmoil. Read More

ValiRx shares fall as ends collaboration with Imperial College London

24th Feb 2025 16:20

(Alliance News) - ValiRx PLC on Monday said it has decided to return the Dual Kinase project to Imperial College London for further development, and will have no further financial commitment to the programme. Read More

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank

31st Dec 2024 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

ValiRx extends TheoremRx exclusivity period to final May 31 deadline

31st Dec 2024 10:58

(Alliance News) - ValiRx PLC on Tuesday said it has extended the exclusivity period for a proposed sub-license agreement with TheoremRx Inc for its VAL201 therapeutic candidate, setting a final deadline of May 31. Read More

See more ValiRx news
FTSE 100 Latest
Value8,554.80
Change23.19

Login to your account

Forgot Password?

Not Registered